APYX MEDICAL CORPORATION
Ownership & governance
Executives 5Directors 5Avg age 62Avg tenure 6y
CG
Charles Goodwin
Chief Executive Officer
Age 60Since 2017-12-14Profile →
+9
Executives5
CG
Charles Goodwin→
Chief Executive Officer
Age 60Since 2017-12-14
MH
Matthew Hill→
Director of Finance/CFO
Age 57Since 2023-12-03
KL
Kari Larson→
Chief Tech/Sci/R&D Officer
—Since 2019-07-31
SR
Shawn Roman→
Chief Operating Officer
Age 54Since 2024-11-05
JF
John Featherstone→
Corporate Officer/Principal
—Since 2025-08-06
Board of directors5
LW
Lawrence Waldman→
Director/Board Member
Age 79Since 2011-03-14
CG
Charles Goodwin→
Director/Board Member
Age 60Since 2017-12-14
MB
Minnie Baylor-Henry→
Director/Board Member
Age 78Since 2019-07-31
WL
Wendy Levine→
Director/Board Member
Age 53Since 2021-08-24
SV
Stavros Vizirgianakis→
Chairman
Age 55Since 2024-05-06
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Nantahala Capital Management LLC | 8.216 % | 3,440,304 |
| Bill Vanderfelt | 7.543 % | 3,158,414 |
| Archon Capital Management LLC | 6.665 % | 2,790,923 |
| Royce & Associates LP | 6.236 % | 2,611,224 |
| Stavros Vizirgianakis | 4.528 % | 1,896,191 |
Catalog · 2026-07-09
SEC officers10
| Name | Role | Since | Shares |
|---|---|---|---|
| Charles Goodwin | Chief Executive Officer | 2017-12-14 | - |
| Kari Larson | Chief Tech/Sci/R&D Officer | 2019-07-31 | - |
| Matthew Hill | Director of Finance/CFO | 2023-12-03 | - |
| Shawn Roman | Chief Operating Officer | 2024-11-05 | - |
| Stavros Vizirgianakis | Chairman | 2024-05-06 | - |
| Charles Goodwin | Director/Board Member | 2017-12-14 | - |
| Lawrence Waldman | Director/Board Member | 2011-03-14 | - |
| Minnie Baylor-Henry | Director/Board Member | 2019-07-31 | - |
SEC · as of 2025-12-31
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus strong buyMean target 6.5Range 6–8Analysts 6
6Mean 6.58
- Strong buy 2
- Buy 4
Broker actions21
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| Maxim Group | Initiated | Buy | 6 | 2026-09-29 |
| HC Wainwright & Co. | Initiated | Buy | 7 | 2026-07-13 |
| Craig-Hallum | Maintained | Buy | 6 | 2026-03-11 |
| BTIG | Upgrade | Buy | 6 | 2026-03-11 |
| Roth Capital | Initiated | Buy | 6 | 2025-12-16 |
| Citizens | Upgrade | Market Outperform | 8 | 2025-11-12 |
| BTIG | Initiated | Neutral | — | 2024-10-17 |
| JMP Securities | Reiterated | Market Perform | — | 2024-09-16 |
| Stephens & Co. | Maintained | Overweight | 5 | 2023-11-10 |
| Piper Sandler | Maintained | Overweight | 4.5 | 2023-08-11 |
| Stephens & Co. | Initiated | Overweight | 8 | 2023-07-14 |
| Lake Street | Maintained | Buy | 9 | 2023-06-15 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.